You are here

COMPLEGEN, INC.

Company Information
Address
1124 COLUMBIA ST, STE 662
SEATTLE, WA 98104-2050
United States



Information

UEI: N/A

# of Employees: N/A


Ownership Information

HUBZone Owned: No

Socially and Economically Disadvantaged: No

Woman Owned: No



Award Charts




Award Listing

  1. A novel therapeutic strategy for Acute Lung Injury: Inhibition of PKC-delta

    Amount: $354,754.00

    DESCRIPTION (provided by applicant): Sepsis and the related systemic inflammatory response are the leading causes of death in intensive care units. More than 200,000 people die each year in the US fro ...

    STTRPhase I2012Department of Health and Human Services National Institutes of Health
  2. A Genetic System For Kinetoplastid Drug Discovery

    Amount: $299,715.00

    DESCRIPTION (provided by applicant): The goal of this project is to apply a novel, well developed cost effective means of drug target and drug discovery to parasitic disease, focusing on Trypanosoma c ...

    SBIRPhase I2003Department of Health and Human Services National Institutes of Health
  3. INDENTIFICATION OF MALE CONTRACEPTIVE LEAD COMPOUNDS

    Amount: $98,808.00

    DESCRIPTION: (provided by applicant) The long-term objective of this project is to identify lead compounds for the development of male contraceptive drugs. The project takes advantage of: 1) ...

    SBIRPhase I2002Department of Health and Human Services National Institutes of Health
  4. HIGH THROUGH-PUT DISCOVERY OF MALARIA DRUG TARGETS

    Amount: $284,047.00

    DESCRIPTION (Provided by applicant): Emerging and re-emerging infectious diseases are some of the most important contributors to pain, suffering and poverty in the developing worl ...

    SBIRPhase I2002Department of Health and Human Services National Institutes of Health
US Flag An Official Website of the United States Government